Logo image
Back
Identification of vimentin as a novel target of HSF4 in lens development and cataract by proteomic analysis
Journal article   Peer reviewed

Identification of vimentin as a novel target of HSF4 in lens development and cataract by proteomic analysis

Lisha Mou, Jing-Ying Xu, Weiye Li, Xia Lei, Yalan Wu, Guoxu Xu, Xiangyin Kong and Guo-Tong Xu
Investigative ophthalmology & visual science, v 51(1), pp 396-404
Jan 2010
DOI: https://doi.org/10.1167/iovs.09-3772
PMID: 19628735
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

alpha-Crystallins Animals beta-Crystallins Blotting, Western Cataract - genetics Cataract - metabolism Cataract - pathology Cell Differentiation DNA-Binding Proteins - physiology Down-Regulation Electrophoresis, Gel, Two-Dimensional Electrophoretic Mobility Shift Assay Gene Expression Regulation - physiology Heat Shock Transcription Factors Heat-Shock Proteins - physiology Immunohistochemistry Lens, Crystalline - embryology Lens, Crystalline - metabolism Lens, Crystalline - pathology Mass Spectrometry Mice Mice, Knockout Plasmids Polymerase Chain Reaction Proteomics Repressor Proteins RNA, Messenger - metabolism Transcription Factors - physiology Vimentin - genetics Vimentin - metabolism
To explore the target genes of HSF4, especially those involved in lens developmental processes and cataract formation. A slit lamp biomicroscopy examination was performed on Hsf4(tm1Xyk)-knockout mice and wild-type mice. Two-dimensional electrophoresis combined with mass spectrometry was used to identify differentially expressed lens proteins between wild-type and Hsf4(tm1Xyk)-knockout mice and further confirmed by Western blot and immunohistochemistry. Histologic analysis was used to analyze the denucleation process of lens fiber cells. Moreover, an electrophoretic mobility shift assay (EMSA), luciferase assay, and chromatin immunoprecipitation (ChIP) assay were used to validate the effects of HSF4 on vimentin expression. Hsf4(tm1Xyk)-knockout mice had abnormal lenses and developed cataract. The downregulated proteins were major structural proteins including alpha- and beta-crystallins, whereas the upregulated proteins were mainly enzymes and an intermediate filament protein, vimentin. The upregulated vimentin expression level was further confirmed by Western blot, Q-PCR, and immunofluorescence. EMSA, luciferase assay, and ChIP assay validated that HSF4 had DNA-binding ability to vimentin promoter and repressed vimentin expression. These findings indicate that HSF4 represses vimentin gene expression via the HSE-like element. The loss of HSF4 function results in an increase in vimentin expression in Hsf4(tm1Xyk)-knockout mice and affects lens differentiation, particularly impairing the denucleation of lens fiber cells. These events appear to implicate a molecular mechanism in abnormal lens development and cataract formation in Hsf4(tm1Xyk)-knockout mice. The HSF4-vimentin axis appears to be a new target for developing anti-cataract drugs, especially for those cataracts resulting from aberrations in HSF4 expression.

Metrics

11 Record Views
26 citations in Web of Science
28 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Ophthalmology
Logo image